NCT04258150 Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT04257955 COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer Status COMPLETED Phase N/A
NCT04247126 A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04245644 Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04241276 A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04210128 Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment Status COMPLETED Phase N/A
NCT04205227 ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04203459 The Mechanism of Enhancing the Anti-tumor Effects of CAR-T on PC by Gut Microbiota Regulation Status UNKNOWN Phase N/A
NCT04193904 A Study of Live Biotherapeutic Product MRx0518 With Hypofractionated Radiation Therapy in Resectable Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT04189393 Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery Status UNKNOWN Phase N/A
NCT04188990 Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition Status COMPLETED Phase NA
NCT04183478 The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT04164602 The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly Status UNKNOWN Phase N/A
NCT04164069 Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab Status COMPLETED Phase PHASE1
NCT04161755 Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04157127 Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma Status RECRUITING Phase PHASE1